STS is also present in colon carcinomas and many colorectal cancer cell lines [62], suggesting that this cancer, which is a major cause of cancer-related deaths in both men and women, might also be a potential target for STS inhibitor therapy [63,64]. This evidence concerns the gene STS and colon carcinoma.